Status: current, Defined. Date: 31-Mar 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3232351000168119 | Irbesartan HCT 300/12.5 (Sanofi) (hydrochlorothiazide 12.5 mg + irbesartan 300 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3232361000168117 | Irbesartan HCT 300/12.5 (Sanofi) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Irbesartan HCT 300/12.5 (Sanofi) tablet | Is a | Irbesartan HCT 300/12.5 (Sanofi) | true | Inferred relationship | Some | ||
| Irbesartan HCT 300/12.5 (Sanofi) tablet | Is a | irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet | true | Inferred relationship | Some | ||
| Irbesartan HCT 300/12.5 (Sanofi) tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Irbesartan HCT 300/12.5 (Sanofi) tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Irbesartan HCT 300/12.5 (Sanofi) tablet | has unit of use | tablet | true | Inferred relationship | Some | 2032605311 | |
| Irbesartan HCT 300/12.5 (Sanofi) tablet | has Australian BoSS | irbesartan | true | Inferred relationship | Some | 922901076 | |
| Irbesartan HCT 300/12.5 (Sanofi) tablet | has intended active ingredient | irbesartan | true | Inferred relationship | Some | 922901076 | |
| Irbesartan HCT 300/12.5 (Sanofi) tablet | has Australian BoSS | hydrochlorothiazide | true | Inferred relationship | Some | 2032605310 | |
| Irbesartan HCT 300/12.5 (Sanofi) tablet | has intended active ingredient | hydrochlorothiazide | true | Inferred relationship | Some | 2032605310 |
Reference Sets
Trade product unit of use reference set
FHIR